Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2015

Quantum Materials (QTMM) Presents at Rodman & Renshaw Conference

Quantum Materials Corp. (OTCBB: QTMM) develops and manufactures Quantum Dots and nanomaterials for use in display, lighting, medical and solar energy through its patented continuous-flow production process. Quantum Materials’ products are the foundation for technologically superior, energy efficient and environmentally … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pure Bioscience (PURE) Presents at Rodman & Renshaw Conference

Pure Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pulmatrix (PULM) Presents at Rodman & Renshaw Conference

Pulmatrix, Inc. (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology. Leveraging the unique capabilities of iSPERSE to dramatically advance inhalation technology, the company means to create new therapies to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Protalex (PRTX) Presents at Rodman & Renshaw Conference

Protalex, Inc. (OTCBB: PRTX) is a biotechnology company developing a new class of drugs with the potential to revolutionize the treatment of autoimmune and inflammatory diseases, including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s lead product, PRTX-100, is a … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Prima BioMed (PBMD) Presents at Rodman & Renshaw Conference

Prima BioMed Ltd. (NASDAQ: PBMD) is a globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products for the treatment of cancer. Prima BioMed is dedicated to leveraging its technology and expertise to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pretium Resources (PVG) Presents at Rodman & Renshaw Conference

Pretium Resources, Inc. (NYSE: PVG) is advancing the high-grade gold Brucejack Project to production. The company is creating value through gold at its 100%-owned, advanced-stage Brucejack Project, which is located 65 kilometers north of the town of Stewart in northern … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

PolyMet Mining (PLM) Presents at Rodman & Renshaw Conference

PolyMet Mining Corp. (NYSE: PLM) is a mine development company focused on permitting, building and operating the NorthMet copper-nickel-precious metals project through its wholly owned subsidiary, Poly Met Mining, Inc., a Minnesota corporation. Through long-term mineral leases, the company controls … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pointer Telocation (PNTR) Presents at Rodman & Renshaw Conference

Pointer Telocation Ltd. (NASDAQ: PNTR) is a leading provider of cutting-edge products and technology, and Software as a Service (SaaS) to the fleet, automotive, insurance, cargo and public-safety industries. Pointer Telocation has a growing client base with products and technologies … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Plug Power (PLUG) Presents at Rodman & Renshaw Conference

Plug Power, Inc. (NASDAQ: PLUG)aims to revolutionize the fuel cell industry with cost-effective solutions that increase productivity, lower operating costs and reduce carbon footprint. Its signature solution, GenKey, provides an all-inclusive package for customers, incorporating GenFuel hydrogen and fueling infrastructure, … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pieris Pharmaceuticals (PIRS) Presents at Rodman & Renshaw Conference

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is a clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Anticalins … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment